SEC Info - Joway Health Industries Group Inc. - ‘10-Q’ for 6/30/22

SEC Info℠

Home

Help

Please Sign In

Joway Health Industries Group Inc. – ‘10-Q’ for 6/30/22 – ‘XML’

On: Wednesday, 8/10/22, at 3:48pm ET · For: 6/30/22 · Accession #: 1213900-22-46308 · File #: 333-108715

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 8/10/22  Joway Health Inds Group Inc.      10-Q        6/30/22   36:1.5M                                   EdgarAgents LLC/FA

Quarterly Report — Form 10-Q

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    227K 
 2: EX-31.1     Certification -- §302 - SOA'02                      HTML     16K 
 3: EX-32.1     Certification -- §906 - SOA'02                      HTML     12K 
 9: R1          Document And Entity Information                     HTML     62K 
10: R2          Balance Sheets                                      HTML     70K 
11: R3          Balance Sheets (Parentheticals)                     HTML     30K 
12: R4          Statements of Operations and Comprehensive Loss     HTML     79K 
                (Unaudited)                                                      
13: R5          Statements of Operations and Comprehensive Loss     HTML     21K 
                (Unaudited) (Parentheticals)                                     
14: R6          Statements of Cash Flows (Unaudited)                HTML     52K 
15: R7          Organization                                        HTML     18K 
16: R8          Going Concern                                       HTML     16K 
17: R9          Summary of Significant Accounting Policies          HTML     33K 
18: R10         Other Payables                                      HTML     15K 
19: R11         Related Party Transactions                          HTML     19K 
20: R12         Income Taxes                                        HTML     19K 
21: R13         Subsequent Events                                   HTML     15K 
22: R14         Accounting Policies, by Policy (Policies)           HTML     56K 
23: R15         Summary of Significant Accounting Policies          HTML     18K 
                (Tables)                                                         
24: R16         Related Party Transactions (Tables)                 HTML     16K 
25: R17         Organization (Details)                              HTML     25K 
26: R18         Going Concern (Details)                             HTML     15K 
27: R19         Summary of Significant Accounting Policies          HTML     31K 
                (Details)                                                        
28: R20         Summary of Significant Accounting Policies          HTML     31K 
                (Details) - Schedule of reconciliation of the                    
                deconsolidation                                                  
29: R21         Other Payables (Details)                            HTML     14K 
30: R22         Related Party Transactions (Details)                HTML     17K 
31: R23         Related Party Transactions (Details) - Schedule of  HTML     20K 
                payables due to related parties                                  
34: XML         IDEA XML File -- Filing Summary                      XML     57K 
32: XML         XBRL Instance -- f10q0622_jowayhealth_htm            XML    180K 
33: EXCEL       IDEA Workbook of Financial Reports                  XLSX     48K 
 5: EX-101.CAL  XBRL Calculations -- gtvi-20220630_cal               XML     46K 
 6: EX-101.DEF  XBRL Definitions -- gtvi-20220630_def                XML    205K 
 7: EX-101.LAB  XBRL Labels -- gtvi-20220630_lab                     XML    486K 
 8: EX-101.PRE  XBRL Presentations -- gtvi-20220630_pre              XML    207K 
 4: EX-101.SCH  XBRL Schema -- gtvi-20220630                         XSD     79K 
35: JSON        XBRL Instance as JSON Data -- MetaLinks              133±   186K 
36: ZIP         XBRL Zipped Folder -- 0001213900-22-046308-xbrl      Zip     86K

‘XML’ — XBRL Instance — f10q0622_jowayhealth_htm

This Document is an XBRL XML File.

<?xml version="1.0" encoding="windows-1252"?>

<link:schemaRef xlink:href="gtvi-20220630.xsd" xlink:type="simple"/>

</entity>

</period>

</context>

</entity>

</period>

</context>

</entity>

</period>

</context>

</entity>

</period>

</context>

</entity>

</period>

</context>

</entity>

</period>

</context>

</entity>

</period>

</context>

</entity>

</period>

</context>

</entity>

</period>

</context>

<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis"> gtvi:CrystalGlobeMember </xbrldi:explicitMember>

</segment>

</entity>

</period>

</context>

</entity>

</period>

</context>

</entity>

</period>

</context>

</entity>

</period>

</context>

<xbrldi:explicitMember dimension="dei:LegalEntityAxis"> gtvi:JowayHealthMember </xbrldi:explicitMember>

</segment>

</entity>

</period>

</context>

<xbrldi:explicitMember dimension="dei:LegalEntityAxis"> gtvi:CrystalGlobeMember </xbrldi:explicitMember>

</segment>

</entity>

</period>

</context>

<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis"> gtvi:JingheZhangMember </xbrldi:explicitMember>

</segment>

</entity>

</period>

</context>

<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis"> gtvi:JingheZhangMember </xbrldi:explicitMember>

</segment>

</entity>

</period>

</context>

<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis"> gtvi:JingheZhangMember </xbrldi:explicitMember>

</segment>

</entity>

</period>

</context>

<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis"> gtvi:JingheZhangMember </xbrldi:explicitMember>

</segment>

</entity>

</period>

</context>

<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis"> gtvi:JingheZhangMember </xbrldi:explicitMember>

</segment>

</entity>

</period>

</context>

<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis"> gtvi:JingheZhangMember </xbrldi:explicitMember>

</segment>

</entity>

</period>

</context>

<measure> shares </measure>

</unit>

</unit>

</unitNumerator>

<measure> shares </measure>

</unitDenominator>

</divide>

</unit>

</unit>

<dei:DocumentType contextRef="c0"> 10-Q </dei:DocumentType>

<dei:DocumentQuarterlyReport contextRef="c0"> true </dei:DocumentQuarterlyReport>

<dei:DocumentPeriodEndDate contextRef="c0"> 2022-06-30 </dei:DocumentPeriodEndDate>

<dei:DocumentFiscalYearFocus contextRef="c0"> 2022 </dei:DocumentFiscalYearFocus>

<dei:DocumentTransitionReport contextRef="c0"> false </dei:DocumentTransitionReport>

<dei:EntityFileNumber contextRef="c0"> 333-108715 </dei:EntityFileNumber>

<dei:EntityRegistrantName contextRef="c0"> Joway Health Industries Group Inc. </dei:EntityRegistrantName>

<dei:EntityIncorporationStateCountryCode contextRef="c0"> NV </dei:EntityIncorporationStateCountryCode>

<dei:EntityTaxIdentificationNumber contextRef="c0"> 98-0221494 </dei:EntityTaxIdentificationNumber>

<dei:EntityAddressAddressLine1 contextRef="c0"> 600 South </dei:EntityAddressAddressLine1>

<dei:EntityAddressAddressLine2 contextRef="c0"> 3rd Street </dei:EntityAddressAddressLine2>

<dei:EntityAddressCityOrTown contextRef="c0"> Las Vegas </dei:EntityAddressCityOrTown>

<dei:EntityAddressStateOrProvince contextRef="c0"> NV </dei:EntityAddressStateOrProvince>

<dei:EntityAddressPostalZipCode contextRef="c0"> 89101 </dei:EntityAddressPostalZipCode>

<dei:CityAreaCode contextRef="c0"> (702) </dei:CityAreaCode>

<dei:LocalPhoneNumber contextRef="c0"> 384-1990 </dei:LocalPhoneNumber>

<dei:EntityCurrentReportingStatus contextRef="c0"> Yes </dei:EntityCurrentReportingStatus>

<dei:EntityInteractiveDataCurrent contextRef="c0"> Yes </dei:EntityInteractiveDataCurrent>

<dei:EntityFilerCategory contextRef="c0"> Non-accelerated Filer </dei:EntityFilerCategory>

<dei:EntitySmallBusiness contextRef="c0"> true </dei:EntitySmallBusiness>

<dei:EntityEmergingGrowthCompany contextRef="c0"> false </dei:EntityEmergingGrowthCompany>

<dei:EntityShellCompany contextRef="c0"> true </dei:EntityShellCompany>

<dei:EntityCommonStockSharesOutstanding contextRef="c1" decimals="INF" unitRef="shares"> 20054000 </dei:EntityCommonStockSharesOutstanding>

<us-gaap:OtherLiabilitiesCurrent contextRef="c2" decimals="0" unitRef="usd"> 143682 </us-gaap:OtherLiabilitiesCurrent>

<us-gaap:OtherLiabilitiesCurrent contextRef="c3" decimals="0" unitRef="usd"> 103053 </us-gaap:OtherLiabilitiesCurrent>

<us-gaap:DueToRelatedPartiesCurrent contextRef="c3" decimals="0" unitRef="usd"> 3999 </us-gaap:DueToRelatedPartiesCurrent>

<us-gaap:LiabilitiesCurrent contextRef="c2" decimals="0" unitRef="usd"> 143682 </us-gaap:LiabilitiesCurrent>

<us-gaap:LiabilitiesCurrent contextRef="c3" decimals="0" unitRef="usd"> 107052 </us-gaap:LiabilitiesCurrent>

<us-gaap:PreferredStockParOrStatedValuePerShare contextRef="c2" decimals="3" unitRef="usdPershares"> 0.001 </us-gaap:PreferredStockParOrStatedValuePerShare>

<us-gaap:PreferredStockParOrStatedValuePerShare contextRef="c3" decimals="3" unitRef="usdPershares"> 0.001 </us-gaap:PreferredStockParOrStatedValuePerShare>

<us-gaap:PreferredStockSharesAuthorized contextRef="c2" decimals="0" unitRef="shares"> 1000000 </us-gaap:PreferredStockSharesAuthorized>

<us-gaap:PreferredStockSharesAuthorized contextRef="c3" decimals="0" unitRef="shares"> 1000000 </us-gaap:PreferredStockSharesAuthorized>

<us-gaap:CommonStockParOrStatedValuePerShare contextRef="c2" decimals="3" unitRef="usdPershares"> 0.001 </us-gaap:CommonStockParOrStatedValuePerShare>

<us-gaap:CommonStockParOrStatedValuePerShare contextRef="c3" decimals="3" unitRef="usdPershares"> 0.001 </us-gaap:CommonStockParOrStatedValuePerShare>

<us-gaap:CommonStockSharesAuthorized contextRef="c2" decimals="0" unitRef="shares"> 200000000 </us-gaap:CommonStockSharesAuthorized>

<us-gaap:CommonStockSharesAuthorized contextRef="c3" decimals="0" unitRef="shares"> 200000000 </us-gaap:CommonStockSharesAuthorized>

<us-gaap:CommonStockSharesIssued contextRef="c2" decimals="0" unitRef="shares"> 20054000 </us-gaap:CommonStockSharesIssued>

<us-gaap:CommonStockSharesIssued contextRef="c3" decimals="0" unitRef="shares"> 20054000 </us-gaap:CommonStockSharesIssued>

<us-gaap:CommonStockSharesOutstanding contextRef="c2" decimals="0" unitRef="shares"> 20054000 </us-gaap:CommonStockSharesOutstanding>

<us-gaap:CommonStockSharesOutstanding contextRef="c3" decimals="0" unitRef="shares"> 20054000 </us-gaap:CommonStockSharesOutstanding>

<us-gaap:CommonStockValue contextRef="c2" decimals="0" unitRef="usd"> 20054 </us-gaap:CommonStockValue>

<us-gaap:CommonStockValue contextRef="c3" decimals="0" unitRef="usd"> 20054 </us-gaap:CommonStockValue>

<us-gaap:AdditionalPaidInCapital contextRef="c2" decimals="0" unitRef="usd"> 7232861 </us-gaap:AdditionalPaidInCapital>

<us-gaap:AdditionalPaidInCapital contextRef="c3" decimals="0" unitRef="usd"> 7228862 </us-gaap:AdditionalPaidInCapital>

<us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c2" decimals="0" unitRef="usd"> -7396597 </us-gaap:RetainedEarningsAccumulatedDeficit>

<us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c3" decimals="0" unitRef="usd"> -7355968 </us-gaap:RetainedEarningsAccumulatedDeficit>

<us-gaap:StockholdersEquity contextRef="c2" decimals="0" unitRef="usd"> -143682 </us-gaap:StockholdersEquity>

<us-gaap:StockholdersEquity contextRef="c3" decimals="0" unitRef="usd"> -107052 </us-gaap:StockholdersEquity>

<us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges contextRef="c4" decimals="0" unitRef="usd"> -30295 </us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges>

<us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges contextRef="c5" decimals="0" unitRef="usd"> -13132 </us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges>

<us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges contextRef="c0" decimals="0" unitRef="usd"> -40629 </us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges>

<us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges contextRef="c6" decimals="0" unitRef="usd"> -96557 </us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges>

<us-gaap:OperatingExpenses contextRef="c4" decimals="0" unitRef="usd"> 30295 </us-gaap:OperatingExpenses>

<us-gaap:OperatingExpenses contextRef="c5" decimals="0" unitRef="usd"> 13132 </us-gaap:OperatingExpenses>

<us-gaap:OperatingExpenses contextRef="c0" decimals="0" unitRef="usd"> 40629 </us-gaap:OperatingExpenses>

<us-gaap:OperatingExpenses contextRef="c6" decimals="0" unitRef="usd"> 96557 </us-gaap:OperatingExpenses>

<us-gaap:OperatingIncomeLoss contextRef="c4" decimals="0" unitRef="usd"> -30295 </us-gaap:OperatingIncomeLoss>

<us-gaap:OperatingIncomeLoss contextRef="c5" decimals="0" unitRef="usd"> -13132 </us-gaap:OperatingIncomeLoss>

<us-gaap:OperatingIncomeLoss contextRef="c0" decimals="0" unitRef="usd"> -40629 </us-gaap:OperatingIncomeLoss>

<us-gaap:OperatingIncomeLoss contextRef="c6" decimals="0" unitRef="usd"> -96557 </us-gaap:OperatingIncomeLoss>

<us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c4" decimals="0" unitRef="usd"> -30295 </us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>

<us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c5" decimals="0" unitRef="usd"> -13132 </us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>

<us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c0" decimals="0" unitRef="usd"> -40629 </us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>

<us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c6" decimals="0" unitRef="usd"> -96557 </us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>

<us-gaap:NetIncomeLoss contextRef="c4" decimals="0" unitRef="usd"> -30295 </us-gaap:NetIncomeLoss>

<us-gaap:NetIncomeLoss contextRef="c5" decimals="0" unitRef="usd"> -13132 </us-gaap:NetIncomeLoss>

<us-gaap:NetIncomeLoss contextRef="c0" decimals="0" unitRef="usd"> -40629 </us-gaap:NetIncomeLoss>

<us-gaap:NetIncomeLoss contextRef="c6" decimals="0" unitRef="usd"> -96557 </us-gaap:NetIncomeLoss>

<us-gaap:ComprehensiveIncomeNetOfTax contextRef="c4" decimals="0" unitRef="usd"> -30295 </us-gaap:ComprehensiveIncomeNetOfTax>

<us-gaap:ComprehensiveIncomeNetOfTax contextRef="c5" decimals="0" unitRef="usd"> -13132 </us-gaap:ComprehensiveIncomeNetOfTax>

<us-gaap:ComprehensiveIncomeNetOfTax contextRef="c0" decimals="0" unitRef="usd"> -40629 </us-gaap:ComprehensiveIncomeNetOfTax>

<us-gaap:ComprehensiveIncomeNetOfTax contextRef="c6" decimals="0" unitRef="usd"> -96557 </us-gaap:ComprehensiveIncomeNetOfTax>

<us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c4" decimals="INF" unitRef="shares"> 20054000 </us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>

<us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c5" decimals="INF" unitRef="shares"> 20054000 </us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>

<us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c0" decimals="INF" unitRef="shares"> 20054000 </us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>

<us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c6" decimals="INF" unitRef="shares"> 20054000 </us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>

<us-gaap:IncomeLossFromContinuingOperations contextRef="c0" decimals="0" unitRef="usd"> -40629 </us-gaap:IncomeLossFromContinuingOperations>

<us-gaap:IncomeLossFromContinuingOperations contextRef="c6" decimals="0" unitRef="usd"> -96557 </us-gaap:IncomeLossFromContinuingOperations>

<gtvi:ReceivableFromDisposalOfSubsidiaries contextRef="c6" decimals="0" unitRef="usd"> 119070 </gtvi:ReceivableFromDisposalOfSubsidiaries>

<gtvi:IncreaseDecreaseInSpecialDividendPayables contextRef="c6" decimals="0" unitRef="usd"> 119070 </gtvi:IncreaseDecreaseInSpecialDividendPayables>

<gtvi:IncreaseDecreaseInOtherPayable contextRef="c0" decimals="0" unitRef="usd"> 40629 </gtvi:IncreaseDecreaseInOtherPayable>

<gtvi:IncreaseDecreaseInOtherPayable contextRef="c6" decimals="0" unitRef="usd"> 29560 </gtvi:IncreaseDecreaseInOtherPayable>

<us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c6" decimals="0" unitRef="usd"> -66997 </us-gaap:NetCashProvidedByUsedInOperatingActivities>

<us-gaap:ProceedsFromRepaymentsOfRelatedPartyDebt contextRef="c6" decimals="0" unitRef="usd"> 66997 </us-gaap:ProceedsFromRepaymentsOfRelatedPartyDebt>

<us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c6" decimals="0" unitRef="usd"> 66997 </us-gaap:NetCashProvidedByUsedInFinancingActivities>

<us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock contextRef="c0">

NOTE 1 – ORGANIZATION Joway Health Industries Group Inc. is herein referred to as “Joway Health”, the “Company,” “we” and “us”. Joway Health (formerly G2 Ventures, Inc.) was originally incorporated under the laws of the State of Nevada on March 21, 2003. On November 20, 2020, Joway Health entered into a Merger Agreement (the “Merger Agreement”) with Dynamic Elite International Limited, a British Virgin Islands company and a wholly-owned subsidiary of the Company (“Dynamic Elite”), Crystal Globe Limited, a British Virgin Islands company (“Parent”) and Joway Merger Subsidiary Limited, a British Virgin Islands company and a wholly-owned subsidiary of Parent (“Merger Sub”). Pursuant to the terms of the Merger Agreement, Merger Sub merged with and into Dynamic Elite (the “Merger”), with Dynamic Elite continuing as the surviving corporation as a wholly-owned subsidiary of Parent. The special committee of the Board of Directors of the Company unanimously approved the Merger Agreement and the transactions contemplated thereby. Pursuant to the terms of the Merger Agreement, at the effective time of the Merger (the “Effective Time”) and as a result of the Merger, the ordinary shares of common stock of Dynamic Elite issued and outstanding immediately prior to the Effective Time, all of which are held by the Company, were cancelled and extinguished in consideration for $119,070 in cash (the “Merger Consideration”). The Company distributed the Merger Consideration to its shareholders (other than to Parent) in an amount equal to such shareholder’s proportionate share of the Merger Consideration based on such shareholders’ percentage of the outstanding common stock of the Company. In addition, the Company received a fairness opinion from an investment banker opining that the Merger Consideration was fair, from a financial point of view, to the shareholders of the Company. As of December 31, 2020, the Effective Time of the Merger, the 10,000 ordinary shares of common stock of Dynamic Elite issued and outstanding immediately which were held by the Company, were cancelled for $119,070 in cash as Merger Consideration, or $0.45 per share. In January 2021, the Company had received $119,070 from Crystal Globe and distributed proportionately to the Company’s minority shareholders, other than Crystal Globe, which represented 2,646,000 shares of our common stock. Since the remaining 17,408,000 shares of our common stock was owned by Crystal Globe, the $0.045 per share payment for the 17,408,000 shares was offset and Crystal Globe did not receive any cash payment in connection with the Merger. On December 31, 2020, upon the Company completed the Merger Agreement with Crystal Globe, Joway Health became a “shell company” (as such term is defined in Rule 12b-2 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Going forward, the Company intends to seek, investigate and, if such investigation warrants, engage in a business combination with a private entity whose business presents an opportunity for the Company’s stockholders.

</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>

<us-gaap:RestrictedCash contextRef="c2" decimals="0" unitRef="usd"> 119070 </us-gaap:RestrictedCash>

<us-gaap:TreasuryStockCommonShares contextRef="c7" decimals="0" unitRef="shares"> 10000 </us-gaap:TreasuryStockCommonShares>

<us-gaap:RestrictedCash contextRef="c7" decimals="0" unitRef="usd"> 119070 </us-gaap:RestrictedCash>

<us-gaap:SharesIssuedPricePerShare contextRef="c7" decimals="2" unitRef="usdPershares"> 0.45 </us-gaap:SharesIssuedPricePerShare>

<us-gaap:CashUninsuredAmount contextRef="c9" decimals="0" unitRef="usd"> 119070 </us-gaap:CashUninsuredAmount>

<us-gaap:TreasuryStockCommonShares contextRef="c9" decimals="0" unitRef="shares"> 2646000 </us-gaap:TreasuryStockCommonShares>

<us-gaap:SharesIssued contextRef="c9" decimals="0" unitRef="shares"> 17408000 </us-gaap:SharesIssued>

<us-gaap:SharesIssuedPricePerShare contextRef="c9" decimals="3" unitRef="usdPershares"> 0.045 </us-gaap:SharesIssuedPricePerShare>

<us-gaap:SharesIssued contextRef="c10" decimals="0" unitRef="shares"> 17408000 </us-gaap:SharesIssued>

<us-gaap:SubstantialDoubtAboutGoingConcernTextBlock contextRef="c0">

NOTE 2 – GOING CONCERN The accompanying unaudited financial statements have been prepared assuming that the Company will continue as a going concern, which contemplates the realization of assets and the discharge of liabilities in the normal course of business for the foreseeable future. As reflected in the accompanying unaudited financial statements, for the six months ended June 30, 2022 and 2021, we incurred net losses of $40,629 and $96,557, respectively. As of June 30, 2022, we had an accumulated deficit of $7.4 million. Management believes these factors raise substantial doubt about our ability to continue as a going concern for the next twelve months. The continuation of our Company as a going concern through the next twelve months is dependent upon the continued financial support from our stockholders or external financing. Management believes that our existing stockholders will provide the additional cash to meet our obligations as they become due. These conditions raise substantial doubt about our company’s ability to continue as a going concern. These financial statements do not include any adjustments to reflect the possible future effect on the recoverability and classification of assets or the amounts and classifications of liabilities that may result from the outcome of these uncertainties. Management believes that the actions presently being taken to obtain additional funding and implement its strategic plan provides the opportunity for our company to continue as a going concern.

</us-gaap:SubstantialDoubtAboutGoingConcernTextBlock>

<gtvi:IncurredNetLosses contextRef="c0" decimals="0" unitRef="usd"> 40629 </gtvi:IncurredNetLosses>

<gtvi:IncurredNetLosses contextRef="c6" decimals="0" unitRef="usd"> 96557 </gtvi:IncurredNetLosses>

<gtvi:AccumulatedDeficit contextRef="c2" decimals="-5" unitRef="usd"> 7400000 </gtvi:AccumulatedDeficit>

<us-gaap:SignificantAccountingPoliciesTextBlock contextRef="c0">

NOTE 3 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The accompanying financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“US GAAP”). After the consummation of the Merger as of December 31, 2020, the Company’s functional currency is USD. Use of Estimates The preparation of the financial statements is in conformity with generally accepted accounting principles in the United States of America, which require management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Management makes these estimates using the best information available at the time the estimates are made. Actual results could differ from those estimates. Other Comprehensive Income Other comprehensive income is defined as the change in equity during the period from transactions and other events, excluding the changes resulting from investments by owners and distributions to owners, and is not included in the computation of income tax expense or benefit. Accumulated other comprehensive income represents the accumulated balance of foreign currency translation adjustments. Concentrations of Credit Risk As a result of the consummation of the Merger, as of December 31, 2020, the Company became a shell company, as that term is defined in Rule 12b-2 of the Exchange Act of 1934, as amended (the “Exchange Act”). Going forward, our main business operations consist of seeking a business combination with a private entity whose business would present an opportunity for its shareholders. Fair Value of Financial Instruments Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 820 establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value as follows: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 24px"> </td> <td style="width: 24px">●</td> <td style="text-align: justify">Level 1—defined as observable inputs such as quoted prices in active markets for identical assets or liabilities;</td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 24px"> </td> <td style="width: 24px">●</td> <td style="text-align: justify">Level 2—defined as inputs other than quoted prices in active markets that are either directly or indirectly observable; and</td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 24px"> </td> <td style="width: 24px">●</td> <td style="text-align: justify">Level 3—defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions.</td></tr> </table> The carrying amounts reported in the balance sheets for cash, accounts receivable, other receivable, accounts payable, other payable, and amounts due from related parties generally approximate their fair market values based on the short-term maturity of these instruments. ASC 825-10 “Financial Instruments” allows entities to voluntarily choose to measure certain financial assets and liabilities at fair value (fair value option). The fair value option may be elected on an instrument-by-instrument basis and is irrevocable, unless a new election date occurs. If the fair value option is elected for an instrument, unrealized gains and losses for that instrument should be reported in earnings at each subsequent reporting date. The Company did not elect to apply the fair value option to any outstanding instruments. Revenue Recognition The Company recognizes revenue when it satisfies a performance obligation by transferring a promised good or service to a customer or the customer obtains control of that asset, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those promised goods or services. After the consummation of the Merger as of December 31, 2020, the Company did not report any revenue for the year ended December 31, 2021 or the first half year ending June 30, 2022. Income Taxes The Company accounts for income taxes in accordance with FASB ASC 740 “Income Taxes” (formerly SFAS No. 109 Accounting for Income Taxes), which is an asset and liability approach that requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been recognized in the Company’s financial statements or tax returns. ASC 740 additionally requires the establishment of a valuation allowance to reflect the likelihood of realization of deferred tax assets. Realization of deferred tax assets is dependent upon future earnings, if any, of which the timing and amount are uncertain. According to ASC 740, the evaluation of a tax position is a two-step process. The first step is to determine whether it is more likely than not that a tax position will be sustained upon examination, including the resolution of any related appeals or litigation based on the technical merits of that position. The second step is to measure a tax position that meets the more-likely-than-not threshold to determine the amount of benefit to be recognized in the financial statements. A tax position is measured at the largest amount of benefit that is greater than 50% likelihood of being realized upon ultimate settlement. Tax positions that previously failed to meet the more-likely-than-not recognition threshold should be recognized in the first subsequent period in which the threshold is met. Previously recognized tax positions that no longer meet the more-likely-than-not criteria should be de-recognized in the first subsequent financial reporting period in which the threshold is no longer met. ASC 740 also provides guidance on de-recognition, classification, interest and penalties, accounting in interim periods, disclosures, and transition. Basic and Diluted Earnings per Share The Company reports earnings per share in accordance with FASB ASC 260 “Earnings per share”. The Company’s basic earnings per share are computed using the weighted average number of shares outstanding for the periods presented. Diluted earnings per share are computed based on the assumption that any dilutive options or warrants were converted or exercised. Dilution is computed by applying the treasury stock method. Under this method, the Company’s outstanding stock warrants are assumed to be exercised, and funds thus obtained were assumed to be used to purchase common stock at the average market price during the period. There were no dilutive instruments outstanding during the three month and six month periods ended June 30, 2022 and 2021. Recently Issued Accounting Pronouncements In December 2019, the FASB issued ASU No. 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes (“ASU 2019-12”), which is intended to simplify various aspects related to accounting for income taxes. ASU 2019-12 removes certain exceptions to the general principles in Topic 740 and also clarifies and amends existing guidance to improve consistent application. This guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020, with early adoption permitted. The Company adopted the standard in 2021. Adoption of the standard did not have a significant impact on the Company’s statement of earnings in 2021. Other accounting standards that have been issued or proposed by the FASB or other standards-setting bodies that do not require adoption until a future date are not expected to have a material impact on the Company’s consolidated financial statements upon adoption. Deconsolidation On November 20, 2020, Joway Health entered into a Merger Agreement (the “Merger Agreement”) with Dynamic Elite International Limited, a British Virgin Islands company and a wholly-owned subsidiary of the Company (“Dynamic Elite”), Crystal Globe Limited, a British Virgin Islands company (“Crystal Globe”) and Joway Merger Subsidiary Limited, a British Virgin Islands company and a wholly-owned subsidiary of Crystal Globe (“Merger Sub”). The Merger Agreement provides that, upon the terms and subject to the satisfaction or waiver of the conditions set forth therein, Merger Sub will be merged with and into Dynamic Elite (the “Merger”), with Dynamic Elite continuing as the surviving corporation as a wholly-owned subsidiary of Crystal Globe. Crystal Globe, as the majority shareholder holding approximately 86.81% of the Company, is also the sole shareholder of Dynamic Elite after the Merger. Mr. Jinghe Zhang, as the former President, former Chief Executive Officer, former Chairman and Director, and the majority beneficial owner of the Company, also serves as sole shareholder and executive director of Crystal Globe. As a result, the Company and Dynamic Elite are under common control of Crystal Globe and Mr. Jinghe Zhang. Pursuant to the terms of the Merger Agreement, at the effective time of the Merger (the “Effective Time”) and as a result of the Merger, the ordinary shares of common stock of Dynamic Elite issued and outstanding immediately prior to the Effective Time, all of which are held by the Company, will be cancelled and extinguished. In accordance with the Merger Agreement, Crystal Globe has offered a cash consideration of $0.045 per share for outstanding shares of Joway Health’s common stock (the “Merger Consideration”). As of November 20, 2020, Joway Health reported 20,054,000 shares of common stock outstanding. As a result, Joway Health recognized a loss of $1,340,795 from this transaction. In January 2021, Joway Health had received $119,070 from Crystal Globe and distributed proportionately to the Company’s minority shareholders, other than Crystal Globe, which represents 2,646,000 shares of Joway Health’s common stock. Since the remaining 17,408,000 shares of Joway Health’s common stock is owned by Crystal Globe, the $0.045 per share payment for the 17,408,000 shares is offset. The following is a reconciliation of the deconsolidation: <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">Amount</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 88%; text-align: justify; padding-bottom: 4pt">Selling price</td><td style="width: 1%; padding-bottom: 4pt"> </td> <td style="width: 1%; border-bottom: Black 4pt double; text-align: left">$</td><td style="width: 9%; border-bottom: Black 4pt double; text-align: right">902,430</td><td style="width: 1%; padding-bottom: 4pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: justify">Disposed assets and liabilities:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Cash</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">79,446</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: justify">Current assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,133,812</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Fixed assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,194,533</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: justify">Intangible assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">465,007</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Liabilities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1,977,822</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: justify; padding-bottom: 1.5pt">Accumulated other comprehensive income</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(651,751</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,243,225</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: justify; padding-bottom: 4pt">Loss from disposal of discontinued component, net of income tax</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(1,340,795</td><td style="padding-bottom: 4pt; text-align: left">)</td></tr> </table>

</us-gaap:SignificantAccountingPoliciesTextBlock>

<us-gaap:ConsolidationPolicyTextBlock contextRef="c0">

Basis of Presentation The accompanying financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“US GAAP”). After the consummation of the Merger as of December 31, 2020, the Company’s functional currency is USD.

</us-gaap:ConsolidationPolicyTextBlock>

<us-gaap:UseOfEstimates contextRef="c0">

Use of Estimates The preparation of the financial statements is in conformity with generally accepted accounting principles in the United States of America, which require management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Management makes these estimates using the best information available at the time the estimates are made. Actual results could differ from those estimates.

</us-gaap:UseOfEstimates>

<us-gaap:ComprehensiveIncomePolicyPolicyTextBlock contextRef="c0">

Other Comprehensive Income Other comprehensive income is defined as the change in equity during the period from transactions and other events, excluding the changes resulting from investments by owners and distributions to owners, and is not included in the computation of income tax expense or benefit. Accumulated other comprehensive income represents the accumulated balance of foreign currency translation adjustments.

</us-gaap:ComprehensiveIncomePolicyPolicyTextBlock>

<us-gaap:ConcentrationRiskCreditRisk contextRef="c0">

Concentrations of Credit Risk As a result of the consummation of the Merger, as of December 31, 2020, the Company became a shell company, as that term is defined in Rule 12b-2 of the Exchange Act of 1934, as amended (the “Exchange Act”). Going forward, our main business operations consist of seeking a business combination with a private entity whose business would present an opportunity for its shareholders.

</us-gaap:ConcentrationRiskCreditRisk>

<us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="c0">

Fair Value of Financial Instruments Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 820 establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value as follows: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 24px"> </td> <td style="width: 24px">●</td> <td style="text-align: justify">Level 1—defined as observable inputs such as quoted prices in active markets for identical assets or liabilities;</td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 24px"> </td> <td style="width: 24px">●</td> <td style="text-align: justify">Level 2—defined as inputs other than quoted prices in active markets that are either directly or indirectly observable; and</td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 24px"> </td> <td style="width: 24px">●</td> <td style="text-align: justify">Level 3—defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions.</td></tr> </table> The carrying amounts reported in the balance sheets for cash, accounts receivable, other receivable, accounts payable, other payable, and amounts due from related parties generally approximate their fair market values based on the short-term maturity of these instruments. ASC 825-10 “Financial Instruments” allows entities to voluntarily choose to measure certain financial assets and liabilities at fair value (fair value option). The fair value option may be elected on an instrument-by-instrument basis and is irrevocable, unless a new election date occurs. If the fair value option is elected for an instrument, unrealized gains and losses for that instrument should be reported in earnings at each subsequent reporting date. The Company did not elect to apply the fair value option to any outstanding instruments.

</us-gaap:FairValueOfFinancialInstrumentsPolicy>

<us-gaap:RevenueRecognitionPolicyTextBlock contextRef="c0">

Revenue Recognition The Company recognizes revenue when it satisfies a performance obligation by transferring a promised good or service to a customer or the customer obtains control of that asset, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those promised goods or services. After the consummation of the Merger as of December 31, 2020, the Company did not report any revenue for the year ended December 31, 2021 or the first half year ending June 30, 2022.

</us-gaap:RevenueRecognitionPolicyTextBlock>

<us-gaap:IncomeTaxPolicyTextBlock contextRef="c0">

Income Taxes The Company accounts for income taxes in accordance with FASB ASC 740 “Income Taxes” (formerly SFAS No. 109 Accounting for Income Taxes), which is an asset and liability approach that requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been recognized in the Company’s financial statements or tax returns. ASC 740 additionally requires the establishment of a valuation allowance to reflect the likelihood of realization of deferred tax assets. Realization of deferred tax assets is dependent upon future earnings, if any, of which the timing and amount are uncertain. According to ASC 740, the evaluation of a tax position is a two-step process. The first step is to determine whether it is more likely than not that a tax position will be sustained upon examination, including the resolution of any related appeals or litigation based on the technical merits of that position. The second step is to measure a tax position that meets the more-likely-than-not threshold to determine the amount of benefit to be recognized in the financial statements. A tax position is measured at the largest amount of benefit that is greater than 50% likelihood of being realized upon ultimate settlement. Tax positions that previously failed to meet the more-likely-than-not recognition threshold should be recognized in the first subsequent period in which the threshold is met. Previously recognized tax positions that no longer meet the more-likely-than-not criteria should be de-recognized in the first subsequent financial reporting period in which the threshold is no longer met. ASC 740 also provides guidance on de-recognition, classification, interest and penalties, accounting in interim periods, disclosures, and transition.

</us-gaap:IncomeTaxPolicyTextBlock>

<us-gaap:EarningsPerSharePolicyTextBlock contextRef="c0">

Basic and Diluted Earnings per Share The Company reports earnings per share in accordance with FASB ASC 260 “Earnings per share”. The Company’s basic earnings per share are computed using the weighted average number of shares outstanding for the periods presented. Diluted earnings per share are computed based on the assumption that any dilutive options or warrants were converted or exercised. Dilution is computed by applying the treasury stock method. Under this method, the Company’s outstanding stock warrants are assumed to be exercised, and funds thus obtained were assumed to be used to purchase common stock at the average market price during the period. There were no dilutive instruments outstanding during the three month and six month periods ended June 30, 2022 and 2021.

</us-gaap:EarningsPerSharePolicyTextBlock>

<us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="c0">

Recently Issued Accounting Pronouncements In December 2019, the FASB issued ASU No. 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes (“ASU 2019-12”), which is intended to simplify various aspects related to accounting for income taxes. ASU 2019-12 removes certain exceptions to the general principles in Topic 740 and also clarifies and amends existing guidance to improve consistent application. This guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020, with early adoption permitted. The Company adopted the standard in 2021. Adoption of the standard did not have a significant impact on the Company’s statement of earnings in 2021. Other accounting standards that have been issued or proposed by the FASB or other standards-setting bodies that do not require adoption until a future date are not expected to have a material impact on the Company’s consolidated financial statements upon adoption.

</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>

<gtvi:DeconsolidationPolicyTextBlock contextRef="c0">

Deconsolidation On November 20, 2020, Joway Health entered into a Merger Agreement (the “Merger Agreement”) with Dynamic Elite International Limited, a British Virgin Islands company and a wholly-owned subsidiary of the Company (“Dynamic Elite”), Crystal Globe Limited, a British Virgin Islands company (“Crystal Globe”) and Joway Merger Subsidiary Limited, a British Virgin Islands company and a wholly-owned subsidiary of Crystal Globe (“Merger Sub”). The Merger Agreement provides that, upon the terms and subject to the satisfaction or waiver of the conditions set forth therein, Merger Sub will be merged with and into Dynamic Elite (the “Merger”), with Dynamic Elite continuing as the surviving corporation as a wholly-owned subsidiary of Crystal Globe. Crystal Globe, as the majority shareholder holding approximately 86.81% of the Company, is also the sole shareholder of Dynamic Elite after the Merger. Mr. Jinghe Zhang, as the former President, former Chief Executive Officer, former Chairman and Director, and the majority beneficial owner of the Company, also serves as sole shareholder and executive director of Crystal Globe. As a result, the Company and Dynamic Elite are under common control of Crystal Globe and Mr. Jinghe Zhang. Pursuant to the terms of the Merger Agreement, at the effective time of the Merger (the “Effective Time”) and as a result of the Merger, the ordinary shares of common stock of Dynamic Elite issued and outstanding immediately prior to the Effective Time, all of which are held by the Company, will be cancelled and extinguished. In accordance with the Merger Agreement, Crystal Globe has offered a cash consideration of $0.045 per share for outstanding shares of Joway Health’s common stock (the “Merger Consideration”). As of November 20, 2020, Joway Health reported 20,054,000 shares of common stock outstanding. As a result, Joway Health recognized a loss of $1,340,795 from this transaction. In January 2021, Joway Health had received $119,070 from Crystal Globe and distributed proportionately to the Company’s minority shareholders, other than Crystal Globe, which represents 2,646,000 shares of Joway Health’s common stock. Since the remaining 17,408,000 shares of Joway Health’s common stock is owned by Crystal Globe, the $0.045 per share payment for the 17,408,000 shares is offset. The following is a reconciliation of the deconsolidation: <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">Amount</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 88%; text-align: justify; padding-bottom: 4pt">Selling price</td><td style="width: 1%; padding-bottom: 4pt"> </td> <td style="width: 1%; border-bottom: Black 4pt double; text-align: left">$</td><td style="width: 9%; border-bottom: Black 4pt double; text-align: right">902,430</td><td style="width: 1%; padding-bottom: 4pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: justify">Disposed assets and liabilities:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Cash</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">79,446</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: justify">Current assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,133,812</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Fixed assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,194,533</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: justify">Intangible assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">465,007</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Liabilities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1,977,822</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: justify; padding-bottom: 1.5pt">Accumulated other comprehensive income</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(651,751</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,243,225</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: justify; padding-bottom: 4pt">Loss from disposal of discontinued component, net of income tax</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(1,340,795</td><td style="padding-bottom: 4pt; text-align: left">)</td></tr> </table>

</gtvi:DeconsolidationPolicyTextBlock>

<gtvi:ShareholderHoldingPercentage contextRef="c0" decimals="4" unitRef="pure"> 0.8681 </gtvi:ShareholderHoldingPercentage>

<gtvi:CashConsiderationPerShare contextRef="c2" decimals="3" unitRef="usdPershares"> 0.045 </gtvi:CashConsiderationPerShare>

<us-gaap:StockIssuedDuringPeriodSharesOther contextRef="c11" decimals="0" unitRef="shares"> 20054000 </us-gaap:StockIssuedDuringPeriodSharesOther>

<us-gaap:NonmonetaryTransactionGainLossRecognizedOnTransfer contextRef="c0" decimals="0" unitRef="usd"> 1340795 </us-gaap:NonmonetaryTransactionGainLossRecognizedOnTransfer>

<gtvi:CashReceived contextRef="c12" decimals="0" unitRef="usd"> 119070 </gtvi:CashReceived>

<gtvi:CommonStockShares contextRef="c13" decimals="0" unitRef="shares"> 2646000 </gtvi:CommonStockShares>

<gtvi:CommonStockShares contextRef="c14" decimals="0" unitRef="shares"> 17408000 </gtvi:CommonStockShares>

<gtvi:PaymentPerShare contextRef="c10" decimals="3" unitRef="usdPershares"> 0.045 </gtvi:PaymentPerShare>

<gtvi:OffsetShares contextRef="c10" decimals="0" unitRef="shares"> 17408000 </gtvi:OffsetShares>

<us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock contextRef="c0">

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">Amount</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 88%; text-align: justify; padding-bottom: 4pt">Selling price</td><td style="width: 1%; padding-bottom: 4pt"> </td> <td style="width: 1%; border-bottom: Black 4pt double; text-align: left">$</td><td style="width: 9%; border-bottom: Black 4pt double; text-align: right">902,430</td><td style="width: 1%; padding-bottom: 4pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: justify">Disposed assets and liabilities:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Cash</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">79,446</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: justify">Current assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,133,812</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Fixed assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,194,533</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: justify">Intangible assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">465,007</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Liabilities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1,977,822</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: justify; padding-bottom: 1.5pt">Accumulated other comprehensive income</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(651,751</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,243,225</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: justify; padding-bottom: 4pt">Loss from disposal of discontinued component, net of income tax</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(1,340,795</td><td style="padding-bottom: 4pt; text-align: left">)</td></tr> </table>

</us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock>

<gtvi:SellingPrice contextRef="c2" decimals="0" unitRef="usd"> 902430 </gtvi:SellingPrice>

<us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c2" decimals="0" unitRef="usd"> 79446 </us-gaap:CashAndCashEquivalentsFairValueDisclosure>

<us-gaap:OtherAssetsCurrent contextRef="c2" decimals="0" unitRef="usd"> 1133812 </us-gaap:OtherAssetsCurrent>

<us-gaap:DeferredTaxLiabilitiesRegulatoryAssets contextRef="c2" decimals="0" unitRef="usd"> 3194533 </us-gaap:DeferredTaxLiabilitiesRegulatoryAssets>

<us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets contextRef="c2" decimals="0" unitRef="usd"> 465007 </us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets>

<us-gaap:OtherLiabilities contextRef="c2" decimals="0" unitRef="usd"> 1977822 </us-gaap:OtherLiabilities>

<us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax contextRef="c2" decimals="0" unitRef="usd"> -651751 </us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>

<gtvi:LossFromDisposalOfDiscontinuedComponentGross contextRef="c2" decimals="0" unitRef="usd"> 2243225 </gtvi:LossFromDisposalOfDiscontinuedComponentGross>

<gtvi:LossFromDisposalOfDiscontinuedComponentNetOfIncomeTax contextRef="c2" decimals="0" unitRef="usd"> -1340795 </gtvi:LossFromDisposalOfDiscontinuedComponentNetOfIncomeTax>

<us-gaap:ScheduleOfDividendPaymentRestrictionsTextBlock contextRef="c0">

NOTE 4 – OTHER PAYABLES As of June 30, 2022 and December 31, 2021, the Company reported $143,682 and $103,053 as its other payables, respectively. The other payables mainly consist of payables for professional services, including audit, legal, and financial statement filing services.

</us-gaap:ScheduleOfDividendPaymentRestrictionsTextBlock>

<us-gaap:DividendPaymentsRestrictionsScheduleStatutoryCapitalAndSurplus1 contextRef="c2" decimals="0" unitRef="usd"> 143682 </us-gaap:DividendPaymentsRestrictionsScheduleStatutoryCapitalAndSurplus1>

<us-gaap:DividendPaymentsRestrictionsScheduleStatutoryCapitalAndSurplus1 contextRef="c3" decimals="0" unitRef="usd"> 103053 </us-gaap:DividendPaymentsRestrictionsScheduleStatutoryCapitalAndSurplus1>

<us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="c0">

NOTE 5 – RELATED PARTY TRANSACTIONS Payables due to related parties consist of the following: <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="white-space: nowrap; font-weight: bold"> </td> <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center">June 30,</td><td style="white-space: nowrap; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold"> </td> <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center">December 31,</td><td style="white-space: nowrap; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Jinghe Zhang</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-70"> -</div></td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">3,999</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 4pt">Total</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-71">-</div></td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">3,999</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table> The amounts owed to related parties are non-interest bearing and have no specified repayment terms. Transactions with Jinghe Zhang The Company was a shell company and has no cash, Mr. Jinghe Zhang, our former President, former Chief Executive Officer and director, agreed to advance operating capital to the Company. For the three months ended March 31, 2022, Mr. Jinghe Zhang released the Company from $3,999.19 of indebtedness owed to him. For the three months ended March 31, 2021, the Company received $3,397 from Mr. Jinghe Zhang. As of June 30, 2022 and December 31, 2021, the total unpaid principal balance due to Mr. Jinghe Zhang for advances was $0 and $3,999, respectively.

</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>

<us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock contextRef="c0">

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="white-space: nowrap; font-weight: bold"> </td> <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center">June 30,</td><td style="white-space: nowrap; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold"> </td> <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center">December 31,</td><td style="white-space: nowrap; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Jinghe Zhang</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-70"> -</div></td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">3,999</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 4pt">Total</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-71">-</div></td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">3,999</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table>

</us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock>

<us-gaap:DueFromRelatedPartiesCurrent contextRef="c20" decimals="0" unitRef="usd"> 3999 </us-gaap:DueFromRelatedPartiesCurrent>

<us-gaap:DueFromRelatedPartiesCurrent contextRef="c3" decimals="0" unitRef="usd"> 3999 </us-gaap:DueFromRelatedPartiesCurrent>

<gtvi:DueFromRelatedPartiesForContinuingOperatingComponent contextRef="c15" decimals="2" unitRef="usd"> 3999.19 </gtvi:DueFromRelatedPartiesForContinuingOperatingComponent>

<gtvi:DueFromRelatedPartiesForContinuingOperatingComponent contextRef="c16" decimals="0" unitRef="usd"> 3397 </gtvi:DueFromRelatedPartiesForContinuingOperatingComponent>

<gtvi:UnpaidPrincipleAmountAdvance contextRef="c17" decimals="0" unitRef="usd"> 0 </gtvi:UnpaidPrincipleAmountAdvance>

<gtvi:UnpaidPrincipleAmountAdvance contextRef="c18" decimals="0" unitRef="usd"> 3999 </gtvi:UnpaidPrincipleAmountAdvance>

<us-gaap:IncomeTaxDisclosureTextBlock contextRef="c0">

NOTE 6 – INCOME TAXES Upon the Company executed the Merger Agreement on December 31, 2020, no provision was made for federal income taxes since the Company has significant net operating losses. The Company’s income tax returns since inception are subject to audit by regulatory authorities. Changes in tax laws and rates could also affect recorded deferred tax assets and liabilities in the future. Management is not aware of any such changes that would have a material effect on the Company’s results of operations, cash flows or financial position. The calculation of our tax liabilities involves dealing with uncertainties in the application of complex tax laws and regulations. FASB ASC Topic 740, Income Taxes provides that a tax benefit from an uncertain tax position may be recognized when it is more likely than not that the position will be sustained upon examination, including resolutions of any related appeals or litigation processes, based on the technical merits. ASC Topic 740 also provides guidance on measurement, derecognition, classification, interest and penalties, accounting in interim periods, disclosure and transition. We recognize tax liabilities in accordance with ASC Topic 740 and we adjust these liabilities when our judgment changes as a result of the evaluation of new information not previously available. Due to the complexity of some of these uncertainties, the ultimate resolution may result in a payment that is materially different from our current estimate of the tax liabilities. These differences will be reflected as increases or decreases to income tax expense in the period in which they are determined.

</us-gaap:IncomeTaxDisclosureTextBlock>

<us-gaap:SubsequentEventsTextBlock contextRef="c0">

NOTE 7 – SUBSEQUENT EVENTS None

</us-gaap:SubsequentEventsTextBlock>

<us-gaap:AssetsCurrent contextRef="c2" id="hidden-fact-0" unitRef="usd" xsi:nil="true"/>

<us-gaap:AssetsCurrent contextRef="c3" id="hidden-fact-1" unitRef="usd" xsi:nil="true"/>

<us-gaap:Assets contextRef="c2" id="hidden-fact-2" unitRef="usd" xsi:nil="true"/>

<us-gaap:Assets contextRef="c3" id="hidden-fact-3" unitRef="usd" xsi:nil="true"/>

<us-gaap:DueToRelatedPartiesCurrent contextRef="c2" id="hidden-fact-4" unitRef="usd" xsi:nil="true"/>

<us-gaap:CommitmentsAndContingencies contextRef="c2" id="hidden-fact-5" unitRef="usd" xsi:nil="true"/>

<us-gaap:CommitmentsAndContingencies contextRef="c3" id="hidden-fact-6" unitRef="usd" xsi:nil="true"/>

<us-gaap:PreferredStockValue contextRef="c2" id="hidden-fact-7" unitRef="usd" xsi:nil="true"/>

<us-gaap:PreferredStockValue contextRef="c3" id="hidden-fact-8" unitRef="usd" xsi:nil="true"/>

<us-gaap:PreferredStockSharesIssued contextRef="c2" id="hidden-fact-9" unitRef="shares" xsi:nil="true"/>

<us-gaap:PreferredStockSharesIssued contextRef="c3" id="hidden-fact-10" unitRef="shares" xsi:nil="true"/>

<us-gaap:PreferredStockSharesOutstanding contextRef="c2" id="hidden-fact-11" unitRef="shares" xsi:nil="true"/>

<us-gaap:PreferredStockSharesOutstanding contextRef="c3" id="hidden-fact-12" unitRef="shares" xsi:nil="true"/>

<us-gaap:LiabilitiesAndStockholdersEquity contextRef="c2" id="hidden-fact-13" unitRef="usd" xsi:nil="true"/>

<us-gaap:LiabilitiesAndStockholdersEquity contextRef="c3" id="hidden-fact-14" unitRef="usd" xsi:nil="true"/>

<us-gaap:Revenues contextRef="c4" id="hidden-fact-15" unitRef="usd" xsi:nil="true"/>

<us-gaap:Revenues contextRef="c5" id="hidden-fact-16" unitRef="usd" xsi:nil="true"/>

<us-gaap:Revenues contextRef="c0" id="hidden-fact-17" unitRef="usd" xsi:nil="true"/>

<us-gaap:Revenues contextRef="c6" id="hidden-fact-18" unitRef="usd" xsi:nil="true"/>

<us-gaap:CostOfGoodsAndServicesSold contextRef="c4" id="hidden-fact-19" unitRef="usd" xsi:nil="true"/>

<us-gaap:CostOfGoodsAndServicesSold contextRef="c5" id="hidden-fact-20" unitRef="usd" xsi:nil="true"/>

<us-gaap:CostOfGoodsAndServicesSold contextRef="c0" id="hidden-fact-21" unitRef="usd" xsi:nil="true"/>

<us-gaap:CostOfGoodsAndServicesSold contextRef="c6" id="hidden-fact-22" unitRef="usd" xsi:nil="true"/>

<us-gaap:GrossProfit contextRef="c4" id="hidden-fact-23" unitRef="usd" xsi:nil="true"/>

<us-gaap:GrossProfit contextRef="c5" id="hidden-fact-24" unitRef="usd" xsi:nil="true"/>

<us-gaap:GrossProfit contextRef="c0" id="hidden-fact-25" unitRef="usd" xsi:nil="true"/>

<us-gaap:GrossProfit contextRef="c6" id="hidden-fact-26" unitRef="usd" xsi:nil="true"/>

<us-gaap:OtherNonoperatingExpense contextRef="c4" id="hidden-fact-27" unitRef="usd" xsi:nil="true"/>

<us-gaap:OtherNonoperatingExpense contextRef="c5" id="hidden-fact-28" unitRef="usd" xsi:nil="true"/>

<us-gaap:OtherNonoperatingExpense contextRef="c0" id="hidden-fact-29" unitRef="usd" xsi:nil="true"/>

<us-gaap:OtherNonoperatingExpense contextRef="c6" id="hidden-fact-30" unitRef="usd" xsi:nil="true"/>

<us-gaap:NonoperatingIncomeExpense contextRef="c4" id="hidden-fact-31" unitRef="usd" xsi:nil="true"/>

<us-gaap:NonoperatingIncomeExpense contextRef="c5" id="hidden-fact-32" unitRef="usd" xsi:nil="true"/>

<us-gaap:NonoperatingIncomeExpense contextRef="c0" id="hidden-fact-33" unitRef="usd" xsi:nil="true"/>

<us-gaap:NonoperatingIncomeExpense contextRef="c6" id="hidden-fact-34" unitRef="usd" xsi:nil="true"/>

<us-gaap:IncomeTaxExpenseBenefit contextRef="c4" id="hidden-fact-35" unitRef="usd" xsi:nil="true"/>

<us-gaap:IncomeTaxExpenseBenefit contextRef="c5" id="hidden-fact-36" unitRef="usd" xsi:nil="true"/>

<us-gaap:IncomeTaxExpenseBenefit contextRef="c0" id="hidden-fact-37" unitRef="usd" xsi:nil="true"/>

<us-gaap:IncomeTaxExpenseBenefit contextRef="c6" id="hidden-fact-38" unitRef="usd" xsi:nil="true"/>

<us-gaap:EarningsPerShareBasic contextRef="c4" id="hidden-fact-39" unitRef="usdPershares" xsi:nil="true"/>

<us-gaap:EarningsPerShareBasic contextRef="c5" id="hidden-fact-40" unitRef="usdPershares" xsi:nil="true"/>

<us-gaap:EarningsPerShareBasic contextRef="c0" id="hidden-fact-41" unitRef="usdPershares" xsi:nil="true"/>

<us-gaap:EarningsPerShareBasic contextRef="c6" id="hidden-fact-42" unitRef="usdPershares" xsi:nil="true"/>

<us-gaap:EarningsPerShareDiluted contextRef="c4" id="hidden-fact-43" unitRef="usdPershares" xsi:nil="true"/>

<us-gaap:EarningsPerShareDiluted contextRef="c5" id="hidden-fact-44" unitRef="usdPershares" xsi:nil="true"/>

<us-gaap:EarningsPerShareDiluted contextRef="c0" id="hidden-fact-45" unitRef="usdPershares" xsi:nil="true"/>

<us-gaap:EarningsPerShareDiluted contextRef="c6" id="hidden-fact-46" unitRef="usdPershares" xsi:nil="true"/>

<us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c4" decimals="INF" id="hidden-fact-47" unitRef="shares"> 20054000 </us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>

<us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c5" decimals="INF" id="hidden-fact-48" unitRef="shares"> 20054000 </us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>

<us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c0" decimals="INF" id="hidden-fact-49" unitRef="shares"> 20054000 </us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>

<us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c6" decimals="INF" id="hidden-fact-50" unitRef="shares"> 20054000 </us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>

<gtvi:ReceivableFromDisposalOfSubsidiaries contextRef="c0" id="hidden-fact-51" unitRef="usd" xsi:nil="true"/>

<gtvi:IncreaseDecreaseInSpecialDividendPayables contextRef="c0" id="hidden-fact-52" unitRef="usd" xsi:nil="true"/>

<us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c0" id="hidden-fact-53" unitRef="usd" xsi:nil="true"/>

<us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c0" id="hidden-fact-54" unitRef="usd" xsi:nil="true"/>

<us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c6" id="hidden-fact-55" unitRef="usd" xsi:nil="true"/>

<us-gaap:ProceedsFromRepaymentsOfRelatedPartyDebt contextRef="c0" id="hidden-fact-56" unitRef="usd" xsi:nil="true"/>

<us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c0" id="hidden-fact-57" unitRef="usd" xsi:nil="true"/>

<us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c0" id="hidden-fact-58" unitRef="usd" xsi:nil="true"/>

<us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c6" id="hidden-fact-59" unitRef="usd" xsi:nil="true"/>

<us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c0" id="hidden-fact-60" unitRef="usd" xsi:nil="true"/>

<us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c6" id="hidden-fact-61" unitRef="usd" xsi:nil="true"/>

<us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c3" id="hidden-fact-62" unitRef="usd" xsi:nil="true"/>

<us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c7" id="hidden-fact-63" unitRef="usd" xsi:nil="true"/>

<us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c2" id="hidden-fact-64" unitRef="usd" xsi:nil="true"/>

<us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c8" id="hidden-fact-65" unitRef="usd" xsi:nil="true"/>

<us-gaap:IncomeTaxesPaid contextRef="c0" id="hidden-fact-66" unitRef="usd" xsi:nil="true"/>

<us-gaap:IncomeTaxesPaid contextRef="c6" id="hidden-fact-67" unitRef="usd" xsi:nil="true"/>

<us-gaap:InterestPaidNet contextRef="c0" id="hidden-fact-68" unitRef="usd" xsi:nil="true"/>

<us-gaap:InterestPaidNet contextRef="c6" id="hidden-fact-69" unitRef="usd" xsi:nil="true"/>

<us-gaap:DueFromRelatedPartiesCurrent contextRef="c19" id="hidden-fact-70" unitRef="usd" xsi:nil="true"/>

<us-gaap:DueFromRelatedPartiesCurrent contextRef="c2" id="hidden-fact-71" unitRef="usd" xsi:nil="true"/>

<dei:AmendmentFlag contextRef="c0"> false </dei:AmendmentFlag>

<dei:CurrentFiscalYearEndDate contextRef="c0"> --12-31 </dei:CurrentFiscalYearEndDate>

<dei:DocumentFiscalPeriodFocus contextRef="c0"> Q2 </dei:DocumentFiscalPeriodFocus>

<dei:EntityCentralIndexKey contextRef="c0"> 0001263364 </dei:EntityCentralIndexKey>

</xbrl>

↑Top

Filing Submission 0001213900-22-046308 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Joway Health Industries Group Inc. – ‘10-Q’ for 6/30/22 – ‘XML’

On: Wednesday, 8/10/22, at 3:48pm ET · For: 6/30/22 · Accession #: 1213900-22-46308 · File #: 333-108715

Previous ‘10-Q’: ‘10-Q’ on 5/12/22 for 3/31/22 · Next: ‘10-Q’ on 11/14/22 for 9/30/22 · Latest: ‘10-Q’ on 12/20/23 for 10/31/23

Quarterly Report — Form 10-QFiling Table of Contents

‘XML’ — XBRL Instance — f10q0622_jowayhealth_htm

This Document is an XBRL XML File.

Quarterly Report — Form 10-Q

Filing Table of Contents